Background illustration for clinical trials search

Paid Clinical Trials Atlanta

Discover 1,670 paid clinical trials in Atlanta, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer

for
Non-Small Cell Lung Cancer
Location: Atlanta GA, Chapel Hill NC, Tampa FL,
Sponsor: Verastem, Inc.

Sex: All

Age: 18+

Code: NCT07659782

Phase 2, Recruiting

CCSH (Compassion-Centered Spiritual Health) for Teams

for
Health Behavior
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT06722027

Recruiting

A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread

for
Prostate Cancer
Location: Atlanta GA, Hackensack NJ, Portland OR
Sponsor: Regeneron Pharmaceuticals

Sex: Male

Age: 18+

Code: NCT07543055

Phase 1, Recruiting

A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Atlanta GA, Nashville TN, Orlando FL, Buffalo NY,
Sponsor: NextCure, Inc.

Sex: All

Age: 18+

Code: NCT06792552

Phase 1, Recruiting

A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)

for
High Risk Smoldering Multiple Myeloma (HR-SMM)
Location: Atlanta GA, Columbus OH, St Louis MO, Detroit MI,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07393282

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)

for
Locally Advanced Basal Cell Carcinoma
Location: Atlanta GA, Durham NC, Tampa FL, Houston TX
Sponsor: Philogen S.p.A.

Sex: All

Age: 18+

Code: NCT07227350

Phase 2, Recruiting

A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)

for
Non-small Cell Lung Cancer (NSCLC),
Location: Atlanta GA, St Louis MO, Fairfax VA, Peoria IL,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT07140016

Phase 1, Recruiting

A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors

for
CLL, Chronic Lymphocytic Leukemia
Location: Atlanta GA, Jacksonville FL, Jonesboro AR, Dayton OH,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06846671

Phase 3, Recruiting

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

for
Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma,
Location: Atlanta GA, Birmingham AL, Durham NC, Indianapolis IN,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT07488676

Phase 1, Phase 2, Recruiting

Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma Refractory, Multiple Myeloma in Relapse
Location: Atlanta GA, Charlotte NC, Winston-Salem NC,
Sponsor: CellCentric Ltd.

Sex: All

Age: 18+

Code: NCT07096778

Phase 2, Recruiting

A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

for
Relapsed and/or Refractory Multiple Myeloma (RRMM)
Location: Atlanta GA, Columbus OH, Houston TX, Dallas TX,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07222761

Phase 3, Recruiting

A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial

for
Human Papillomavirus-Related Carcinoma
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 9+

Code: NCT07104240

Recruiting

Study of Biomarker-Based Treatment of Acute Myeloid Leukemia

for
Previously Untreated Relapsed Refractory Acute Myeloid Leukemia
Location: Atlanta GA, Chapel Hill NC, Cincinnati OH, Columbus OH,
Sponsor: Beat AML, LLC

Sex: All

Age: 18+

Code: NCT03013998

Phase 2, Phase 3, Recruiting

ProAgio in Combination With Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer

for
Triple Negative Breast Cancer
Location: Atlanta GA
Sponsor: ProDa BioTech, LLC

Sex: All

Age: 18+

Code: NCT06460298

Phase 1, Phase 2, Recruiting

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

for
Haematological Malignancy, Acute Myeloid Leukemia,
Location: Atlanta GA, Indianapolis IN, Bethesda MD,
Sponsor: CellCentric Ltd.

Sex: All

Age: 18+

Code: NCT04068597

Phase 1, Phase 2, Recruiting

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

for
Relapsed/Refractory Multiple Myeloma
Location: Atlanta GA, Birmingham AL, Columbus OH, St Louis MO,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT04973605

Phase 1, Phase 2, Recruiting

Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

for
Hearing Loss, Head and Neck Cancer
Location: Atlanta GA, Fairfax VA, Bethesda MD, Baltimore MD,
Sponsor: National Institute on Deafness and Other Communication Disorders (NIDCD)

Sex: All

Age: 18 - 70+

Code: NCT04915183

Phase 2, Recruiting

Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy

for
Malignant Solid Neoplasm
Location: Atlanta GA, Birmingham AL, Greer SC, Hendersonville NC,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05642611

Phase 3, Recruiting

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

for
Chronic Graft-Versus-Host Disease (cGVHD)
Location: Atlanta GA, Nashville TN, Charlotte NC, Lexington KY,
Sponsor: Deciphera Pharmaceuticals, LLC

Sex: All

Age: 18+

Code: NCT06619561

Phase 2, Recruiting

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

for
Cardiotoxicity, HER2/Neu Positive,
Location: Atlanta GA, Gainesville GA, Greenville SC,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT03418961

Phase 3, Recruiting